My ePortfolio Register   

Acquired resistance to EGFR antibodies

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 05.07.17
Views: 663

Dr Federica Di Nicolantonio - Candiolo Cancer Institute, Turin, Italy

Dr Di Nicolantonio talks with ecancer at ESMO GI 2017 about acquired resistance to EGFR antibodies in colorectal cancer and how this is managed.

She also discusses how to act upon some of the molecular mechanisms of drug resistance in colorectal cancer, and the clincal implications behind this research.

Related videos

follow us

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

Cancer Intelligence